We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
LGC Clinical Diagnostics

Download Mobile App




Breast Cancer Risk Decreases When Walnuts Are Included in Diet

By LabMedica International staff writers
Posted on 14 Sep 2011
Print article
The risk of breast cancer dropped significantly in lab mice when their regular diet included a small amount of walnut, researchers recently reported.

The study, led by Elaine Hardman, PhD, from Marshall’s Joan C. Edwards School of Medicine (Huntington, WV, USA), compared the effects of a typical diet and a diet containing walnuts across the lifespan: through the mother from conception through weaning, and then through eating the food directly. The amount of walnut in the test diet equates to approximately 2 ounces per day for humans.

Dr. Hardman stated that during the study period, the group whose diet included walnut at both stages developed breast cancer at less than half the rate of the group with the typical diet. In addition, the number of tumors and their sizes were considerably smaller. “These reductions are particularly important when you consider that the mice were genetically programmed to develop cancer at a high rate,” Dr. Hardman said. “We were able to reduce the risk for cancer even in the presence of a preexisting genetic mutation.”

The article, published online August 11, 2011, in the journal Nutrition and Cancer noted that dietary modification studies do not show whether benefits result from what is added to a diet or what is removed. In this instance, adding healthy fat and other components meant that unhealthy fat was reduced to keep total dietary fat balanced in the mice. Dr. Hardman reported that other studies have distinctly shown, however, that multiple ingredients in walnuts reduce the risk of cancer or slow its growth.

Using genetic analysis, the Marshall study found that the walnut-containing diet changed the activity of multiple genes that are relevant to breast cancer in both mice and humans. Other testing revealed that increases in omega 3 fatty acids did not fully account for the anticancer effect, and found that tumor growth decreased when dietary vitamin E increased.

Dr. Hardman noted that the findings emphasize the key role diet plays in health. “Food is important medicine in our diet,” she said. “What we put into our bodies makes a big difference--it determines how the body functions, our reaction to illness and health. The simple stuff really works: eat right, get off the couch, and turn off the TV. The results of this study indicate that increased consumption of walnut could be part of a healthy diet and reduce risk for cancer in future generations.”

Related Links:

Marshall’s Joan C. Edwards School of Medicine



New
Gold Member
Serological Pipet Controller
PIPETBOY GENIUS
Automated Blood Typing System
IH-500 NEXT
New
Gold Member
Pneumocystis Jirovecii Detection Kit
Pneumocystis Jirovecii Real Time RT-PCR Kit
New
Cortisol Rapid Test
Finecare Cortisol Rapid Quantitative Test

Print article

Channels

Clinical Chemistry

view channel
Image: The new saliva-based test for heart failure measures two biomarkers in about 15 minutes (Photo courtesy of Trey Pittman)

POC Saliva Testing Device Predicts Heart Failure in 15 Minutes

Heart failure is a serious condition where the heart muscle is unable to pump sufficient oxygen-rich blood throughout the body. It ranks as a major cause of death globally and is particularly fatal for... Read more

Hematology

view channel
Image: The smartphone technology measures blood hemoglobin levels from a digital photo of the inner eyelid (Photo courtesy of Purdue University)

First-Of-Its-Kind Smartphone Technology Noninvasively Measures Blood Hemoglobin Levels at POC

Blood hemoglobin tests are among the most frequently conducted blood tests, as hemoglobin levels can provide vital insights into various health conditions. However, traditional tests are often underutilized... Read more

Immunology

view channel
Image: Under a microscope, DNA repair is visible as bright green spots (“foci”) in the blue-stained cell DNA. Orange highlights actively growing cancer cells (Photo courtesy of WEHI)

Simple Blood Test Could Detect Drug Resistance in Ovarian Cancer Patients

Every year, hundreds of thousands of women across the world are diagnosed with ovarian and breast cancer. PARP inhibitors (PARPi) therapy has been a major advancement in treating these cancers, particularly... Read more

Microbiology

view channel
Image: HNL Dimer can be a novel and potentially useful clinical tool in antibiotic stewardship in sepsis (Photo courtesy of Shutterstock)

Unique Blood Biomarker Shown to Effectively Monitor Sepsis Treatment

Sepsis remains a growing problem across the world, linked to high rates of mortality and morbidity. Timely and accurate diagnosis, along with effective supportive therapy, is essential in reducing sepsis-related... Read more

Pathology

view channel
Image: The artificial intelligence models can personalize immune therapies in oncology patients (Photo courtesy of 123RF)

AI Tool Identifies Novel Genetic Signatures to Personalize Cancer Therapies

Lung cancer and bladder cancer are among the most commonly diagnosed cancers globally. Researchers have now developed artificial intelligence (AI) models designed to personalize immune therapies for oncology... Read more

Technology

view channel
Image: Schematic diagram of nanomaterial-based anti-epileptic drug concentration diagnostic technology (Photo courtesy of KRISS)

Nanomaterial-Based Diagnostic Technology Accurately Monitors Drug Therapy in Epilepsy Patients

Many patients with epilepsy take anti-epileptic drugs to control frequent seizures in their daily lives. To optimize treatment and avoid side effects from overdosing, it is crucial for patients to regularly... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.